BioSeed Capital reinforced its presence in the TTS Latin America conference held in Miami

Paula Cañal
Nov 30, 2017

 After the rewarding experience in the past two annuals of the TTS Global Initiative in Medellín and Santiago de Compostela, BioSeed Capital took part in the latest conference as part of the international speakers.

Juan R. García, managing partner at the Biotechnology Business Institute and BioSeed Capital, traveled to Miami last 28th of November for the last TTS Global Initiative conference. In this occasion, the second annual concerning Latin American countries gathered stakeholder groups from all over the globe dated in search of an effective relationship between the main actors involved in the pharmaceutical and biotechnology industry.

New this year, there was a great focus on networking and building business relations between the main actors of the between the top institutions and early-stage biotech companies in Latin America, and leading US and European TTOs, institutions, investors, entrepreneurs, pharma, large biotech and industry.

Once again, BioSeed Capital was invited to take part in the conference, after the rewarding experience lived in the past two annuals of the TTS Global Initiative, held in Medellín, Colombia – TTS Latin America – and Santiago the Compostela – TTS Europe – during 2016 and 2017 respectively. Our Chairman, Juan R. García, was one of the international speakers that talked about the biotech start-up funding and SMEs in Latin America. García explained during the panel discussion what the investors are looking for in this growing sector of life sciences.

Latest news

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

The Biotechnology Business Institute inaugurated the fifth edition of the master’s programs with the consolidation of its innovative educational model, Discover&Transfer

After the success of the first edition of the Discover&Transfer program, the new students of the Biotechnology Business Institute will develop new patents from the main research institutions of Barcelona.

The Biotechnology Business Institute signs a strategic collaboration agreement with IRB Barcelona, the Fundació Bosch i Gimpera and UPF, promoted by UPF Ventures, in a new educational model for drug discovery and technology transfer

The Biotechnology Business Institute (BBI) incorporates Discover & Transfer to the programs, where the students will be working with real drug candidates of these three institutions.

BIOSPAIN 2018 consolidates the congress as the 5th world biotechnology event

The ninth edition of the BIOSPAIN International Biotechnology Meeting, which ASEBIO organizes every two years, brought together more than 600 companies from 30 countries in the city of Seville.

Filter by category